Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis
- PMID: 11753642
- DOI: 10.1038/sj.onc.1204980
Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis
Abstract
Development of strategies for prevention of breast cancer development requires an understanding of the effects of mammary oncogenes on mammary cells at early stages in neoplastic transformation. As mammary oncogenes wnt-1 and int-2 affect different signal transduction pathways, we investigated their effects on established mouse mammary epithelial cell lines (MMECLs) reflecting early stages in tumorigenesis. Normal interactions between beta-catenin and E-cadherin were abrogated in all three immortalized MMECLs and the cells lacked beta-catenin-mediated transactivation activity, detectable using a reporter assay, suggesting that alterations in cell adhesion may be very early events in mammary tumorigenesis. Immortalized FSK4 and EL12 cells and hyperplastic TM3 cells were stably transfected with expression vectors encoding wnt-1 or int-2 or the control vector, and drug-selected pooled cells from each line were confirmed by reverse transcription-polymerase chain reaction to express the transfected oncogene; this expression persisted in the cells analysed in vitro and in vivo. Resultant phenotypic changes depended both on the oncogene and the target mammary cell line. In FSK4 cells, expression of wnt-1 or int-2 resulted in proliferative changes in vitro, including reduced contact inhibition, increased beta-catenin expression, and decreased p53 transcriptional activity, but neither oncogene conferred upon those cells the ability to produce tumors in vivo. EL12 cells were highly refractory to the effects of both oncogenes, with the only measurable changes being increased E-cadherin levels induced by both oncogenes and increased proliferation of the int-2-transfected cells in the absence of serum. Parental TM3 cells were phenotypically similar to wnt-1- or int-2-transfected FSK4 cells and displayed an increased rate of proliferation in vitro and markedly increased tumorigenicity in vivo following transfection with int-2 but not with wnt-1. These results suggest that wnt-1 signaling is redundant in the hyperplastic TM3 cells and indicate that wnt-1-induced effects in the immortalized FSK4 and EL12 cells were not sufficient to mediate a tumorigenic phenotype. This study showed that the wnt-1 and int-2 oncogenes have similar but distinguishable effects on immortalized MMECLs and that the genetic background of the mammary cells greatly influences the consequences of oncogene expression at early stages of cell transformation.
Similar articles
-
Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.Oncogene. 2003 Dec 18;22(58):9243-53. doi: 10.1038/sj.onc.1207217. Oncogene. 2003. PMID: 14681683
-
Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.Oncogene. 2002 Aug 15;21(36):5548-56. doi: 10.1038/sj.onc.1205686. Oncogene. 2002. PMID: 12165853
-
Stably transfected HC11 cells provide an in vitro and in vivo model system for studying Wnt gene function.Cell Growth Differ. 1997 Aug;8(8):839-49. Cell Growth Differ. 1997. PMID: 9269893
-
Catenins, Wnt signaling and cancer.Bioessays. 2000 Nov;22(11):961-5. doi: 10.1002/1521-1878(200011)22:11<961::AID-BIES1>3.0.CO;2-T. Bioessays. 2000. PMID: 11056471 Review.
-
The promise and perils of Wnt signaling through beta-catenin.Science. 2002 May 31;296(5573):1644-6. doi: 10.1126/science.1071549. Science. 2002. PMID: 12040179 Review.
Cited by
-
Wnt2 complements Wnt/β-catenin signaling in colorectal cancer.Oncotarget. 2015 Nov 10;6(35):37257-68. doi: 10.18632/oncotarget.6133. Oncotarget. 2015. PMID: 26484565 Free PMC article.
-
Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2.J Immunol. 2013 Jun 1;190(11):5894-902. doi: 10.4049/jimmunol.1203141. Epub 2013 May 3. J Immunol. 2013. PMID: 23645882 Free PMC article.
-
Tumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway.J Biol Chem. 2011 Jan 21;286(3):2111-20. doi: 10.1074/jbc.M110.154971. Epub 2010 Nov 19. J Biol Chem. 2011. PMID: 21097507 Free PMC article.
-
Upregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakia.PLoS One. 2012;7(6):e38648. doi: 10.1371/journal.pone.0038648. Epub 2012 Jun 18. PLoS One. 2012. PMID: 22719913 Free PMC article.
-
MCPIP1 Selectively Destabilizes Transcripts Associated with an Antiapoptotic Gene Expression Program in Breast Cancer Cells That Can Elicit Complete Tumor Regression.Cancer Res. 2016 Mar 15;76(6):1429-40. doi: 10.1158/0008-5472.CAN-15-1115. Epub 2016 Feb 1. Cancer Res. 2016. PMID: 26833120 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous